Active Pharmaceutical Ingredients (API) Market Report

China Active Pharmaceutical Ingredients (API) Industry Market Research Report 2023-2029

  • POSTDATE：Oct 03, 2023
  • PAGES：202
  • REPORT CODE：GMM1821879
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Active Pharmaceutical Ingredients (API) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis International AG

    • Teva Pharmaceutical Industries Ltd

    • Almac group PLC

    • CordenPharma GmbH

    • Saneca Pharmaceutical AS

    • GlaxoSmithKline PLC

    • Aesica Pharmaceuticals, Ltd

    • Siegfried Holding AG

    • Fareva SA

    • Boehringer Ingelheim International GmbH

    By Type:

    • Synthetic Chemical API

    • Biological API

    By Application:

    • Other Therapeutics Uses

    • Genito-urinary disorders

    • Metabolic disorders

    • Gastrointestinal

    • Musculo-skeletal disorders

    • Central nervous system

    • Respiratory system

    • Oncology

    • Anti-infectives

    • Cardiovascular and hematopoietic system

    • Hormonal related disorders

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Active Pharmaceutical Ingredients (API) Market Overview 2018-2029

    • 1.1 China Active Pharmaceutical Ingredients (API) Industry Development Overview

    • 1.2 China Active Pharmaceutical Ingredients (API) Industry Development History

    • 1.3 China Active Pharmaceutical Ingredients (API) Industry Market Size (2018-2029)

    • 1.4 China Active Pharmaceutical Ingredients (API) Market Analysis by Type from Production Side

      • 1.4.1 China Active Pharmaceutical Ingredients (API) Production Volume, Production Value and Growth Rate of Synthetic Chemical API (2018-2029)

      • 1.4.2 China Active Pharmaceutical Ingredients (API) Production Volume, Production Value and Growth Rate of Biological API (2018-2029)

    • 1.5 China Active Pharmaceutical Ingredients (API) Market Analysis by Application from Consumption End

      • 1.5.1 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Other Therapeutics Uses (2018-2029)

      • 1.5.2 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Genito-urinary disorders (2018-2029)

      • 1.5.3 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Metabolic disorders (2018-2029)

      • 1.5.4 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Gastrointestinal (2018-2029)

      • 1.5.5 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Musculo-skeletal disorders (2018-2029)

      • 1.5.6 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Central nervous system (2018-2029)

      • 1.5.7 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Respiratory system (2018-2029)

      • 1.5.8 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.9 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Anti-infectives (2018-2029)

      • 1.5.10 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Cardiovascular and hematopoietic system (2018-2029)

      • 1.5.11 China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Hormonal related disorders (2018-2029)

    • 1.6 China Active Pharmaceutical Ingredients (API) Market Analysis by Region

      • 1.6.1 North China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Active Pharmaceutical Ingredients (API) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Active Pharmaceutical Ingredients (API) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Active Pharmaceutical Ingredients (API) Market Status and Competition Analysis in 2023

      • 2.2.3 China Active Pharmaceutical Ingredients (API) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Active Pharmaceutical Ingredients (API) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Active Pharmaceutical Ingredients (API) Industry Development

    Chapter 3 Active Pharmaceutical Ingredients (API)Industry Chain Analysis

    • 3.1 Active Pharmaceutical Ingredients (API) Industry Chain

    • 3.2 Active Pharmaceutical Ingredients (API) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Active Pharmaceutical Ingredients (API) Market

    • 3.3 Active Pharmaceutical Ingredients (API) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Active Pharmaceutical Ingredients (API) Market

    Chapter 4 China Active Pharmaceutical Ingredients (API) Market, by Type

    • 4.1 China Active Pharmaceutical Ingredients (API) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Active Pharmaceutical Ingredients (API) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Active Pharmaceutical Ingredients (API) Production Volume and Growth Rate, by Type

      • 4.5.1 China Active Pharmaceutical Ingredients (API) Production Volume and Growth Rate of Synthetic Chemical API

      • 4.5.2 China Active Pharmaceutical Ingredients (API) Production Volume and Growth Rate of Biological API

    Chapter 5 China Active Pharmaceutical Ingredients (API) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Active Pharmaceutical Ingredients (API) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate, by Application

      • 5.5.1 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Other Therapeutics Uses

      • 5.5.2 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Genito-urinary disorders

      • 5.5.3 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Metabolic disorders

      • 5.5.4 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Gastrointestinal

      • 5.5.5 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Musculo-skeletal disorders

      • 5.5.6 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Central nervous system

      • 5.5.7 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Respiratory system

      • 5.5.8 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Oncology

      • 5.5.9 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Anti-infectives

      • 5.5.10 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Cardiovascular and hematopoietic system

      • 5.5.11 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Hormonal related disorders

    Chapter 6 China Active Pharmaceutical Ingredients (API) Market, by Region

    • 6.1 China Active Pharmaceutical Ingredients (API) Production Volume and Production Value, by Region

    • 6.2 China Active Pharmaceutical Ingredients (API) Sales Volume and Sales Value, by Region

    Chapter 7 North China Active Pharmaceutical Ingredients (API) Market Analysis

    • 7.1 North China Active Pharmaceutical Ingredients (API) Market, by Type

    • 7.2 North China Active Pharmaceutical Ingredients (API) Market, by Application

    Chapter 8 Central China Active Pharmaceutical Ingredients (API) Market Analysis

    • 8.1 Central China Active Pharmaceutical Ingredients (API) Market, by Type

    • 8.2 Central China Active Pharmaceutical Ingredients (API) Market, by Application

    Chapter 9 South China Active Pharmaceutical Ingredients (API) Market Analysis

    • 9.1 South China Active Pharmaceutical Ingredients (API) Market, by Type

    • 9.2 South China Active Pharmaceutical Ingredients (API) Market, by Application

    Chapter 10 East China Active Pharmaceutical Ingredients (API) Market Analysis

    • 10.1 East China Active Pharmaceutical Ingredients (API) Market, by Type

    • 10.2 East China Active Pharmaceutical Ingredients (API) Market, by Application

    Chapter 11 Northeast China Active Pharmaceutical Ingredients (API) Market Analysis

    • 11.1 Northeast China Active Pharmaceutical Ingredients (API) Market, by Type

    • 11.2 Northeast China Active Pharmaceutical Ingredients (API) Market, by Application

    Chapter 12 Southwest China Active Pharmaceutical Ingredients (API) Market Analysis

    • 12.1 Southwest China Active Pharmaceutical Ingredients (API) Market, by Type

    • 12.2 Southwest China Active Pharmaceutical Ingredients (API) Market, by Application

    Chapter 13 Northwest China Active Pharmaceutical Ingredients (API) Market Analysis

    • 13.1 Northwest China Active Pharmaceutical Ingredients (API) Market, by Type

    • 13.2 Northwest China Active Pharmaceutical Ingredients (API) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis International AG

        • 14.1.1 Novartis International AG Company Profile

        • 14.1.2 Novartis International AG Active Pharmaceutical Ingredients (API) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Teva Pharmaceutical Industries Ltd

        • 14.2.1 Teva Pharmaceutical Industries Ltd Company Profile

        • 14.2.2 Teva Pharmaceutical Industries Ltd Active Pharmaceutical Ingredients (API) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Almac group PLC

        • 14.3.1 Almac group PLC Company Profile

        • 14.3.2 Almac group PLC Active Pharmaceutical Ingredients (API) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 CordenPharma GmbH

        • 14.4.1 CordenPharma GmbH Company Profile

        • 14.4.2 CordenPharma GmbH Active Pharmaceutical Ingredients (API) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Saneca Pharmaceutical AS

        • 14.5.1 Saneca Pharmaceutical AS Company Profile

        • 14.5.2 Saneca Pharmaceutical AS Active Pharmaceutical Ingredients (API) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 GlaxoSmithKline PLC

        • 14.6.1 GlaxoSmithKline PLC Company Profile

        • 14.6.2 GlaxoSmithKline PLC Active Pharmaceutical Ingredients (API) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Aesica Pharmaceuticals, Ltd

        • 14.7.1 Aesica Pharmaceuticals, Ltd Company Profile

        • 14.7.2 Aesica Pharmaceuticals, Ltd Active Pharmaceutical Ingredients (API) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Siegfried Holding AG

        • 14.8.1 Siegfried Holding AG Company Profile

        • 14.8.2 Siegfried Holding AG Active Pharmaceutical Ingredients (API) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Fareva SA

        • 14.9.1 Fareva SA Company Profile

        • 14.9.2 Fareva SA Active Pharmaceutical Ingredients (API) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Boehringer Ingelheim International GmbH

        • 14.10.1 Boehringer Ingelheim International GmbH Company Profile

        • 14.10.2 Boehringer Ingelheim International GmbH Active Pharmaceutical Ingredients (API) Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Active Pharmaceutical Ingredients (API) Industry Research Conclusions

    • 15.2 Active Pharmaceutical Ingredients (API) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Active Pharmaceutical Ingredients (API) Industry Market Size (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Production Volume, Production Value and Growth Rate of Synthetic Chemical API (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Production Volume, Production Value and Growth Rate of Biological API (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Other Therapeutics Uses (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Genito-urinary disorders (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Metabolic disorders (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Gastrointestinal (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Musculo-skeletal disorders (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Central nervous system (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Respiratory system (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Anti-infectives (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Cardiovascular and hematopoietic system (2018-2029)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume, Sales Value and Growth Rate of Hormonal related disorders (2018-2029)

    • Figure North China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

    • Figure Central China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

    • Figure South China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

    • Figure East China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate from 2018-2029

    • Figure Active Pharmaceutical Ingredients (API) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Active Pharmaceutical Ingredients (API) Market Share by Type in 2018

    • Figure China Active Pharmaceutical Ingredients (API) Market Share by Type in 2023

    • Figure China Active Pharmaceutical Ingredients (API) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Production Volume and Growth Rate of Synthetic Chemical API (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Production Volume and Growth Rate of Biological API (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Share by Application in 2018

    • Figure China Active Pharmaceutical Ingredients (API) Market Share by Application in 2023

    • Figure China Active Pharmaceutical Ingredients (API) Total Market Size and Growth Rate from Consumption End

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Other Therapeutics Uses (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Genito-urinary disorders (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Metabolic disorders (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Gastrointestinal (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Musculo-skeletal disorders (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Central nervous system (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Respiratory system (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Anti-infectives (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Cardiovascular and hematopoietic system (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate of Hormonal related disorders (2018-2023)

    • Table China Active Pharmaceutical Ingredients (API) Production Volume by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients (API) Production Volume Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Production Volume Share by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients (API) Production Value by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients (API) Production Value Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Production Value Share by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients (API) Sales Volume by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients (API) Sales Volume Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Volume Share by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients (API) Sales Value by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients (API) Sales Value Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredients (API) Sales Value Share by Region (2018-2023)

    • Table North China Active Pharmaceutical Ingredients (API) Production Volume by Type (2018-2023)

    • Table North China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Figure North China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Table North China Active Pharmaceutical Ingredients (API) Sales Volume by Application (2018-2023)

    • Table North China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Figure North China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Table Central China Active Pharmaceutical Ingredients (API) Production Volume by Type (2018-2023)

    • Table Central China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Figure Central China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Table Central China Active Pharmaceutical Ingredients (API) Sales Volume by Application (2018-2023)

    • Table Central China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Figure Central China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Table South China Active Pharmaceutical Ingredients (API) Production Volume by Type (2018-2023)

    • Table South China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Figure South China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Table South China Active Pharmaceutical Ingredients (API) Sales Volume by Application (2018-2023)

    • Table South China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Figure South China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Table East China Active Pharmaceutical Ingredients (API) Production Volume by Type (2018-2023)

    • Table East China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Figure East China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Table East China Active Pharmaceutical Ingredients (API) Sales Volume by Application (2018-2023)

    • Table East China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Figure East China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredients (API) Production Volume by Type (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredients (API) Sales Volume by Application (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredients (API) Production Volume by Type (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredients (API) Sales Volume by Application (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredients (API) Production Volume by Type (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Active Pharmaceutical Ingredients (API) Production Volume Share by Type (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredients (API) Sales Volume by Application (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG Active Pharmaceutical Ingredients (API) Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries Ltd Company Profile

    • Table Teva Pharmaceutical Industries Ltd Active Pharmaceutical Ingredients (API) Revenue, Price and Gross (2018-2023)

    • Table Almac group PLC Company Profile

    • Table Almac group PLC Active Pharmaceutical Ingredients (API) Revenue, Price and Gross (2018-2023)

    • Table CordenPharma GmbH Company Profile

    • Table CordenPharma GmbH Active Pharmaceutical Ingredients (API) Revenue, Price and Gross (2018-2023)

    • Table Saneca Pharmaceutical AS Company Profile

    • Table Saneca Pharmaceutical AS Active Pharmaceutical Ingredients (API) Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline PLC Company Profile

    • Table GlaxoSmithKline PLC Active Pharmaceutical Ingredients (API) Revenue, Price and Gross (2018-2023)

    • Table Aesica Pharmaceuticals, Ltd Company Profile

    • Table Aesica Pharmaceuticals, Ltd Active Pharmaceutical Ingredients (API) Revenue, Price and Gross (2018-2023)

    • Table Siegfried Holding AG Company Profile

    • Table Siegfried Holding AG Active Pharmaceutical Ingredients (API) Revenue, Price and Gross (2018-2023)

    • Table Fareva SA Company Profile

    • Table Fareva SA Active Pharmaceutical Ingredients (API) Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim International GmbH Company Profile

    • Table Boehringer Ingelheim International GmbH Active Pharmaceutical Ingredients (API) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US